U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13N4O4S.Na
Molecular Weight 332.311
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFADIMETHOXINE SODIUM

SMILES

[Na+].COC1=NC(OC)=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=C1

InChI

InChIKey=DQDZQHMCPDUUPC-UHFFFAOYSA-N
InChI=1S/C12H13N4O4S.Na/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9;/h3-7H,13H2,1-2H3;/q-1;+1

HIDE SMILES / InChI

Molecular Formula C12H14N4O4S
Molecular Weight 310.329
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://www.fda.gov/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm118359.htm; http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/02/WC500138474.pdf

Sulfadimethoxine is a sulfonamide antibacterial used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years and is available as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies. In USA and Europe sulfadimethoxine is approved in a veterinary medicinal products. ANADA was approved by FDA in US in 1997 as an Over the Counter medicine for treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. Sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine. Bioequivalence for this generic animal drug, Sulfadimethoxine Injection 40%, was established by demonstration of chemical equivalence to the pioneer product, Hoffmann-La Roche's Albon® Injection 40% (NADA 041-245).

Originator

Curator's Comment: Sulfadimethoxine (madribon) was developed in the late 1950s. # Roche Laboratories, Division of Hoffman-La Roche Inc

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
ANADA

Approved Use

For treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine

Launch Date

1997
Curative
ANADA

Approved Use

For treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine

Launch Date

1997
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
3%
SULFADIMETHOXINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
7%
SULFADIMETHOXINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
500 mg 2 times / day multiple, oral
Studied dose
Dose: 500 mg, 2 times / day
Route: oral
Route: multiple
Dose: 500 mg, 2 times / day
Sources:
unhealthy, 20
Health Status: unhealthy
Age Group: 20
Sex: F
Sources:
Disc. AE: Cholestatic jaundice...
AEs leading to
discontinuation/dose reduction:
Cholestatic jaundice (mild)
Sources:
500 mg 1 times / day multiple, oral
Studied dose
Dose: 500 mg, 1 times / day
Route: oral
Route: multiple
Dose: 500 mg, 1 times / day
Sources:
unhealthy
Health Status: unhealthy
Sex: M+F
Sources:
AEs

AEs

AESignificanceDosePopulation
Cholestatic jaundice mild
Disc. AE
500 mg 2 times / day multiple, oral
Studied dose
Dose: 500 mg, 2 times / day
Route: oral
Route: multiple
Dose: 500 mg, 2 times / day
Sources:
unhealthy, 20
Health Status: unhealthy
Age Group: 20
Sex: F
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Diagnosis and treatment of Eimeria macusaniensis in an adult alpaca with signs of colic.
2009-03
Salmonella in healthy pigs: prevalence, serotype diversity and antimicrobial resistance observed during 1998-1999 and 2004-2005 in Japan.
2008-08
Performance of blue-yellow screening test for antimicrobial detection in ovine milk.
2007-12
Organic solvents-free technique for determining sulfadimethoxine and its metabolites in chicken meat.
2007-11-16
Efficacy of eleven antimicrobials against a gregarine parasite (Apicomplexa: Protozoa).
2007-11-12
Cytotoxicity is predicted by unbound and not total bilirubin concentration.
2007-11
Analytical methods for multiresidue determination of sulfonamides and trimethoprim in meat and ground water samples by CE-MS and CE-MS/MS.
2007-11
Determination of sulphonamides in animal tissues by high performance liquid chromatography with pre-column derivatization of 9-fluorenylmethyl chloroformate.
2007-11
[Simultaneous determination of nine sulfonamide residues in milk using solid phase extraction and high performance liquid chromatography].
2007-09
Determination of residues of sulphonamide in eggs and laying hens.
2007-07
Use of sulfadimethoxine in intensive calf farming: evaluation of transfer to stable manure and soil.
2007-06
Determination of 10 sulfonamide residues in meat samples by liquid chromatography with ultraviolet detection.
2007-05-04
Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea.
2007-04
Validation of an analytical method to determine sulfamides in kidney by HPLC-DAD and PARAFAC2 with first-order derivative chromatograms.
2007-03-28
Simultaneous determination of 17 sulfonamides and the potentiators ormetoprim and trimethoprim in salmon muscle by liquid chromatography with tandem mass spectrometry detection.
2007-03-22
Development of an immunochromatographic lateral-flow test strip for rapid detection of sulfonamides in eggs and chicken muscles.
2007-03-21
Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats.
2007-03
Observational study of hepatic cytochrome P-450 protein expression and activity in summer flounder (Paralichtys dentatus) after combination ormetoprim-sulfadimethoxine treatment.
2007
Antimicrobial susceptibility of Shiga toxin-producing Escherichia coli isolated from organic dairy farms, conventional dairy farms, and county fairs in Minnesota.
2007
NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity.
2007
Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats.
2007
In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.
2007
Oxidation of sulfonamide antimicrobials by ferrate(VI) [Fe(VI)O4(2-)].
2006-12-01
Characterization of bacterial susceptibility isolates in sixteen dairy farms in Taiwan.
2006-12
Sulfadimethoxine degradation kinetics in manure as affected by initial concentration, moisture, and temperature.
2006-10-31
Determination of sulfonamide antibiotics in wastewater: a comparison of solid phase microextraction and solid phase extraction methods.
2006-10-27
Determination of antimicrobials in sludge from infiltration basins at two artificial recharge plants by pressurized liquid extraction-liquid chromatography-tandem mass spectrometry.
2006-10-13
Application of capillary zone electrophoresis with large-volume sample stacking to the sensitive determination of sulfonamides in meat and ground water.
2006-10
Exhaustive extraction of sulfonamide antibiotics from aged agricultural soils using pressurized liquid extraction.
2006-09-22
Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA.
2006-09
Biliverdin-induced brainstem auditory evoked potential abnormalities in the jaundiced Gunn rat.
2006-08-30
Multiresidue determination of sulfonamides in edible catfish, shrimp and salmon tissues by high-performance liquid chromatography with postcolumn derivatization and fluorescence detection.
2006-08-18
Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine.
2006-07
Calculated in vivo free bilirubin levels in the central nervous system of Gunn rat pups.
2006-07
Absence of in vivo genotoxic potential and tumor initiation activity of kojic acid in the rat thyroid.
2006-05-15
Evaluation of changes in antimicrobial susceptibility patterns of Pasteurella multocida subsp multocida isolates from pigs in Spain in 1987-1988 and 2003-2004.
2006-04
Prevalence and characterization of Escherichia coli O157 isolates from Minnesota dairy farms and county fairs.
2006-02
Degradation kinetics of manure-derived sulfadimethoxine in amended soil.
2006-01-11
Simultaneous determination of 16 sulfonamides in honey by liquid chromatography/tandem mass spectrometry.
2006-01-03
Comparison of enhancing effects of different goitrogen treatments in combination with beta-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds.
2006-01
Sex-specific regional brain bilirubin content in hyperbilirubinemic Gunn rat pups.
2006
Simultaneous extraction and analysis of 11 tetracycline and sulfonamide antibiotics in influent and effluent domestic wastewater by solid-phase extraction and liquid chromatography-electrospray ionization tandem mass spectrometry.
2005-12-02
The jaundiced gunn rat model of auditory neuropathy/dyssynchrony.
2005-12
[Determination of residual sulfonamides in meat by high performance liquid chromatography with solid-phase extraction].
2005-11
Determination of pKa values by capillary zone electrophoresis with a dynamic coating procedure.
2005-11
Actinomyces naeslundii infection in an African hedgehog (Atelerix albiventris) with mandibular osteomyelitis and cellulitis.
2005-10-08
Confirmation of sulfamethazine, sulfathiazole, and sulfadimethoxine residues in condensed milk and soft-cheese products by liquid chromatography/tandem mass spectrometry.
2005-07-09
[Qualification and quantification of 10 sulfonamides in animal feedstuff by high performance liquid chromatography-electrospray tandem mass spectrometry].
2005-07
Effects of sodium chlorate on antibiotic resistance in Escherichia coli O157:H7.
2004
Anti-cryptosporidial drug activity screened with an immunosuppressed rat model.
1991-11-01
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: ANADA, a generic product and the pioneer product Albon have identical indications for use in cattle.
25 mg/lb initial dose of ANADA followed by 12.5 mg/lb for maintenance doses every 24 hours.
Route of Administration: Intravenous
Sulfadimethoxine MIC of <256 mg/ml was determined against Arcanobacterium pyogenes isolated from the lungs of white-tailed deer (Odocoileus virginianus) with pneumonia
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:10:42 GMT 2025
Edited
by admin
on Mon Mar 31 18:10:42 GMT 2025
Record UNII
49DG2B481W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DI-METHOX
Preferred Name English
SULFADIMETHOXINE SODIUM
USP   WHO-DD  
Common Name English
SULFADIMETHOXINE SODIUM SALT [MI]
Common Name English
Sulfadimethoxine sodium [WHO-DD]
Common Name English
SULFADIMETHOXINE SODIUM [USP MONOGRAPH]
Common Name English
SODIUM SULFADIMETHOXINE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29739
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
Code System Code Type Description
FDA UNII
49DG2B481W
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
PUBCHEM
13384041
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
SMS_ID
300000023743
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
NCI_THESAURUS
C76976
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
ChEMBL
CHEMBL62193
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
RXCUI
1306121
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY RxNorm
MERCK INDEX
m10307
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY Merck Index
CAS
1037-50-9
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
DAILYMED
49DG2B481W
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
EPA CompTox
DTXSID50858735
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
DRUG BANK
DBSALT000956
Created by admin on Mon Mar 31 18:10:42 GMT 2025 , Edited by admin on Mon Mar 31 18:10:42 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
FOR VETERINARY USE
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY